Term ends May 23, 2032 · High confidence
20-year base term ends May 23, 2032
Held by BioNTech SE
Filed Jul 2, 2020 as application 16/920,286 · Granted Feb 15, 2022
Base term, 20 years from filing
Today
2012
2032
Clock starts
May 23, 2012
May 23, 2012
Term ends
May 23, 2032
May 23, 2032
Granted
Feb 15, 2022
Feb 15, 2022
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 23, 2012, when application PCT/EP2012/002209, the earliest non-provisional in its chain, was filed (this one was filed Jul 2, 2020) | May 23, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 23, 2032 | High confidence |
Partial family
| Application PCT/EP2012/002209 | PCT application no patent term | no patent term |
| US 10,738,355 | In force May 2032 | May 2032 |
| US 11,248,264 | this patent May 2032 | May 2032 |
| Application 17/576,170 | Pending not computed | not computed |
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 17, 2020 Reel 53241, frame 43 | Sahin, Ugur; Kreiter, Sebastian; Diken, Mustafa; Diekmann, Jan; Koslowski, Michael; Britten, Cedrik; Castle, John Christopher; Lower, Martin; Renard, Bernhard; Omokoko, Tana; De Graaf, Johannes Hendrikus | BioNTech AG; Tron-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Ggmbh | Assignment of Assignor's Interest |
| Jul 17, 2020 Reel 53241, frame 58 | BioNTech AG | BioNTech Rna Pharmaceuticals GmbH | Assignment of Assignor's Interest |
| Jul 17, 2020 reel/frame not recorded | Castle, John Christopher; Diekmann, Jan; Kreiter, Sebastian; Lower, Martin; Sahin, Ugur; Renard, Bernhard; Omokoko, Tana; Britten, Cedrik; De Graaf, Johannes Hendrikus; Diken, Mustafa; Koslowski, Michael | BioNTech AG | Assignment of Assignor's Interest |
| Jul 17, 2020 reel/frame not recorded | Castle, John Christopher; Diekmann, Jan; Kreiter, Sebastian; Lower, Martin; Sahin, Ugur; Renard, Bernhard; Omokoko, Tana; Britten, Cedrik; De Graaf, Johannes Hendrikus; Diken, Mustafa; Koslowski, Michael | Tron-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Ggmbh | Assignment of Assignor's Interest |
| Nov 17, 2021 Reel 58167, frame 1 | BioNTech Rna Pharmaceuticals GmbH; BioNTech SE | BioNTech SE | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2032
Term ends May 23, 2032. Maintenance fees still fall due before then
Citations
3
later US patents cite this one
That is above the median of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.